At the end of November, the Supreme Administrative Court published a breakthrough judgment for the pharmaceutical sector in case 3 Afs 54/2020-73 Eli Lilly. That judgment concerned the provision of marketing services by a pharmaceutical distributor to a foreign entity belonging to the same group of companies in order to ensure profitability, which could not be achieved in a standard way because of price regulation.
Source Deloitte
Latest Posts in "Czech Republic"
- EU Approves VAT Modernization: Electronic Invoicing and Digital Reporting by 2030
- EU Packaging Regulation Faces Legal Challenges Over Reusability, Plastic Ban, and Deposit Requirements
- ECJ VAT C-513/24 (Oblastní nemocnice Kolín) – AG Opinion – Costs for non-deductible VAT activities do not guarantee proportional deductions
- Czech Tax Authority Launches Campaign to Inspect Online Retailers’ Income Reporting for Tax Compliance
- Czech Republic to Implement Updated NACE Codes from January 2026 for VAT Compliance
